| Literature DB >> 35567655 |
Runting Li1, Fa Lin1, Yu Chen1, Junlin Lu1, Heze Han1, Li Ma1, Yahui Zhao1, Debin Yan1, Ruinan Li1, Jun Yang1, Shihao He1, Zhipeng Li1, Haibin Zhang1, Kexin Yuan1, Ke Wang1, Qiang Hao1, Xun Ye1, Hao Wang1, Hongliang Li2, Linlin Zhang2, Guangzhi Shi2, Jianxin Zhou2, Yang Zhao3, Yukun Zhang3, Youxiang Li4, Shuo Wang1,5,6,7, Xiaolin Chen8,9,10, Yuanli Zhao1,3,5,6,7.
Abstract
This study aimed to establish a new scoring model based on the early brain injury (EBI) indicators to predict the 90-day functional outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively enrolled 825 patients and prospectively enrolled 108 patients with aSAH who underwent surgical clipping or endovascular coiling (derivation cohort = 640; validation cohort = 185; prospective cohort = 108) in our institute. We established a logistic regression model based on independent risk factors associated with 90-day unfavorable outcomes. The discrimination of the prognostic model was assessed by the area under the curve in a receiver operating characteristic curve analysis. The Hosmer-Lemeshow goodness-of-fit test and a calibration plot were used to evaluate the calibration of the prediction model. The developed scoring model named "TAPS" (total score, 0-7 points) included the following admission variables: age > 55 years old, WFNS grade of 4-5, mFS grade of 3-4, Graeb score of 5-12, white blood cell count > 11.28 × 109/L, and surgical clipping. The model showed good discrimination with the area under the curve in the derivation, validation, and prospective cohorts which were 0.816 (p < 0.001, 95%CI = 0.77-0.86), 0.810 (p < 0.001, 95%CI = 0.73-0.90), and 0.803 (p < 0.001, 95%CI = 0.70-0.91), respectively. The model also demonstrated good calibration (Hosmer-Lemeshow goodness-of-fit test: X2 = 1.75, df = 8, p = 0.988). Compared with other predictive models, TAPS is an easy handle tool for predicting the 90-day unfavorable outcomes of aSAH patients, which can help clinicians better understand the concept of EBI and quickly identify those patients at risk of poor prognosis, providing more positive treatment strategies. Trial registration: NCT04785976. Registered 5 March 2021-retrospectively registered, http://www.clinicaltrials.gov .Entities:
Keywords: Aneurysmal subarachnoid hemorrhage; Early brain injury; Functional outcome; Model
Year: 2022 PMID: 35567655 DOI: 10.1007/s12975-022-01033-4
Source DB: PubMed Journal: Transl Stroke Res ISSN: 1868-4483 Impact factor: 6.829